SCHEMBL21767185

SCHEMBL21767185

COc1cccc(-c2nnc(NSCP3CC3)n2-c2c(OC)cccc2OC)n1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21767040 0.78 APLNR (0.70) APLNR
SCHEMBL21766935 0.77 APLNR (0.71) APLNR
SCHEMBL21767161 0.77 APLNR (0.71) APLNR
SCHEMBL21766931 0.76 APLNR (0.71) APLNR
SCHEMBL18246356 0.75 APLNR (1.00) APLNR
SCHEMBL18245820 0.75 APLNR (1.00) APLNR
SCHEMBL18254024 0.74 APLNR (0.65) APLNR
SCHEMBL21767105 0.73 APLNR (0.71) APLNR
SCHEMBL18246622 0.73 APLNR (1.00) APLNR
SCHEMBL18245674 0.72 APLNR (1.00) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 EP disclosed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP disclosed